{"id":"sodium-bicarbonate-7-5-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypernatremia"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Metabolic alkalosis (with overcorrection)"},{"rate":null,"effect":"Phlebitis at injection site"},{"rate":null,"effect":"Hypocalcemia"}]},"_chembl":{"chemblId":"CHEMBL1353","moleculeType":"Small molecule","molecularWeight":"84.01"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium bicarbonate dissociates in the bloodstream to provide bicarbonate ions (HCO3−), which buffer excess hydrogen ions and raise serum pH. This mechanism is used to treat metabolic acidosis from various causes including diabetic ketoacidosis, lactic acidosis, and renal failure. The 7.5% concentration provides a moderate dose suitable for intravenous administration in acute care settings.","oneSentence":"Sodium bicarbonate acts as a systemic alkalinizing agent that increases blood pH and bicarbonate concentration to counteract metabolic acidosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:23.310Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metabolic acidosis"},{"name":"Diabetic ketoacidosis"},{"name":"Lactic acidosis"},{"name":"Renal tubular acidosis"},{"name":"Severe diarrhea-induced acidosis"}]},"trialDetails":[{"nctId":"NCT06551779","phase":"NA","title":"Efficacy of Perineural Injection With Dextrose Versus Therapy Conventional Physics in Patients With Bell's Palsy","status":"COMPLETED","sponsor":"Celia Itxelt Infante Castro","startDate":"2024-02-09","conditions":"Bell´s Palsy","enrollment":21},{"nctId":"NCT02647892","phase":"PHASE4","title":"Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2016-01-08","conditions":"Local Anesthesia","enrollment":70},{"nctId":"NCT04054128","phase":"PHASE4","title":"Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients","status":"UNKNOWN","sponsor":"Hospital General \"Dr. Miguel Silva\" de Morelia","startDate":"2019-09-11","conditions":"End Stage Renal Disease, Vascular Access Complication, Catheter Complications","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Bicarnat® arm"],"phase":"marketed","status":"active","brandName":"Sodium Bicarbonate 7.5% Injection","genericName":"Sodium Bicarbonate 7.5% Injection","companyName":"Hospital General \"Dr. Miguel Silva\" de Morelia","companyId":"hospital-general-dr-miguel-silva-de-morelia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium bicarbonate acts as a systemic alkalinizing agent that increases blood pH and bicarbonate concentration to counteract metabolic acidosis. Used for Metabolic acidosis, Diabetic ketoacidosis, Lactic acidosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}